By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS



Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





Company News
Merrimack Pharmaceuticals Inc. (MACK)To Present Clinical And Biomarker Data On Novel Antibody Therapeutics At The ESMO 2014 Congress 9/19/2014 7:18:06 AM
Merrimack Pharmaceuticals Inc. (MACK) Reports Second Quarter 2014 Financial Results 8/11/2014 7:41:11 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of HERMIONE, A Randomized Trial Of MM-302 In Patients With Advanced HER2-Positive Breast Cancer To Support Application For Accelerated Approval 8/11/2014 7:33:02 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Second Quarter 2014 Investor Conference Call 8/4/2014 3:38:56 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents Data From Phase 3 NAPOLI-1 Study At The ESMO 16th World Congress On Gastrointestinal Cancer 6/26/2014 7:39:47 AM
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/20/2014 6:57:26 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Oral Presentation Of Additional Data Results In Phase 3 NAPOLI-1 Study At The ESMO 16th World Congress On Gastrointestinal Cancer 6/17/2014 8:50:14 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Phase 1 Clinical Data Supporting Four Novel Antibody Therapeutic Programs At The 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 4:52:04 PM
Merrimack Pharmaceuticals Inc. (MACK) Identifies Heregulin As Patient Response Biomarker For MM-121 And Standard Of Care Therapy Across Multiple Cancers 6/2/2014 9:28:51 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/27/2014 9:15:01 AM
12345678910...
//-->